PLAYSTUDIOS INC (MYPS) Fundamental Analysis & Valuation

NASDAQ:MYPS • US72815G1085

Current stock price

0.4759 USD
+0 (+0.49%)
Last:

This MYPS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. MYPS Profitability Analysis

1.1 Basic Checks

  • MYPS had negative earnings in the past year.
  • In the past year MYPS had a positive cash flow from operations.
  • MYPS had negative earnings in 4 of the past 5 years.
  • MYPS had a positive operating cash flow in each of the past 5 years.
MYPS Yearly Net Income VS EBIT VS OCF VS FCFMYPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

1.2 Ratios

  • MYPS has a worse Return On Assets (-9.85%) than 65.82% of its industry peers.
  • Looking at the Return On Equity, with a value of -12.57%, MYPS is in line with its industry, outperforming 44.30% of the companies in the same industry.
Industry RankSector Rank
ROA -9.85%
ROE -12.57%
ROIC N/A
ROA(3y)-8.01%
ROA(5y)-5.18%
ROE(3y)-10.34%
ROE(5y)-6.68%
ROIC(3y)N/A
ROIC(5y)N/A
MYPS Yearly ROA, ROE, ROICMYPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • MYPS's Gross Margin of 75.56% is amongst the best of the industry. MYPS outperforms 82.28% of its industry peers.
  • MYPS's Gross Margin has improved in the last couple of years.
  • MYPS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.3%
GM growth 5Y2.71%
MYPS Yearly Profit, Operating, Gross MarginsMYPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. MYPS Health Analysis

2.1 Basic Checks

  • MYPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MYPS has more shares outstanding
  • MYPS has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for MYPS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MYPS Yearly Shares OutstandingMYPS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
MYPS Yearly Total Debt VS Total AssetsMYPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • MYPS has an Altman-Z score of 1.24. This is a bad value and indicates that MYPS is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.24, MYPS perfoms like the industry average, outperforming 54.43% of the companies in the same industry.
  • MYPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.24
ROIC/WACCN/A
WACC9.45%
MYPS Yearly LT Debt VS Equity VS FCFMYPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • MYPS has a Current Ratio of 3.12. This indicates that MYPS is financially healthy and has no problem in meeting its short term obligations.
  • MYPS has a better Current ratio (3.12) than 88.61% of its industry peers.
  • A Quick Ratio of 3.12 indicates that MYPS has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.12, MYPS belongs to the best of the industry, outperforming 88.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.12
Quick Ratio 3.12
MYPS Yearly Current Assets VS Current LiabilitesMYPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. MYPS Growth Analysis

3.1 Past

  • MYPS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.64%, which is quite good.
  • Looking at the last year, MYPS shows a very negative growth in Revenue. The Revenue has decreased by -18.77% in the last year.
  • MYPS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.72% yearly.
EPS 1Y (TTM)13.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)-18.77%
Revenue growth 3Y-6.79%
Revenue growth 5Y-2.72%
Sales Q2Q%-18.26%

3.2 Future

  • The Earnings Per Share is expected to grow by 40.76% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, MYPS will show a decrease in Revenue. The Revenue will decrease by -0.12% on average per year.
EPS Next Y44.17%
EPS Next 2Y40.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.59%
Revenue Next 2Y-3.64%
Revenue Next 3Y-0.12%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MYPS Yearly Revenue VS EstimatesMYPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
MYPS Yearly EPS VS EstimatesMYPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.1 -0.2

More info and screens

Find the best growth stocksShow best growing peers

2

4. MYPS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MYPS. In the last year negative earnings were reported.
  • Also next year MYPS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYPS Price Earnings VS Forward Price EarningsMYPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, MYPS is valued cheaper than 96.20% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.09
EV/EBITDA -2.52
MYPS Per share dataMYPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • MYPS's earnings are expected to grow with 40.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.76%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MYPS Dividend Analysis

5.1 Amount

  • MYPS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MYPS Fundamentals: All Metrics, Ratios and Statistics

PLAYSTUDIOS INC

NASDAQ:MYPS (3/25/2026, 10:51:01 AM)

0.4759

+0 (+0.49%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)03-16
Earnings (Next)05-01
Inst Owners37.28%
Inst Owner Change2.9%
Ins Owners3.06%
Ins Owner Change0.07%
Market Cap60.01M
Revenue(TTM)235.10M
Net Income(TTM)-28.64M
Analysts78.18
Price Target1.79 (276.13%)
Short Float %2.23%
Short Ratio6.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-168.59%
Min EPS beat(2)-217.96%
Max EPS beat(2)-119.22%
EPS beat(4)0
Avg EPS beat(4)-100.84%
Min EPS beat(4)-217.96%
Max EPS beat(4)-15.34%
EPS beat(8)2
Avg EPS beat(8)-54.69%
EPS beat(12)5
Avg EPS beat(12)-70.06%
EPS beat(16)8
Avg EPS beat(16)-11.56%
Revenue beat(2)0
Avg Revenue beat(2)-3.62%
Min Revenue beat(2)-3.84%
Max Revenue beat(2)-3.41%
Revenue beat(4)0
Avg Revenue beat(4)-4.29%
Min Revenue beat(4)-5.61%
Max Revenue beat(4)-3.41%
Revenue beat(8)2
Avg Revenue beat(8)-2.7%
Revenue beat(12)4
Avg Revenue beat(12)-1.63%
Revenue beat(16)6
Avg Revenue beat(16)-0.78%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-1.37%
Revenue NY rev (3m)-4.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF 6.09
P/OCF 2.28
P/B 0.26
P/tB 0.6
EV/EBITDA -2.52
EPS(TTM)-0.19
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)0.08
FCFY16.41%
OCF(TTM)0.21
OCFY43.89%
SpS1.86
BVpS1.81
TBVpS0.79
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.85%
ROE -12.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.56%
FCFM 4.19%
ROA(3y)-8.01%
ROA(5y)-5.18%
ROE(3y)-10.34%
ROE(5y)-6.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.3%
GM growth 5Y2.71%
F-Score6
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 43%
Cap/Sales 7.02%
Interest Coverage N/A
Cash Conversion 146.99%
Profit Quality N/A
Current Ratio 3.12
Quick Ratio 3.12
Altman-Z 1.24
F-Score6
WACC9.45%
ROIC/WACCN/A
Cap/Depr(3y)54.83%
Cap/Depr(5y)81.52%
Cap/Sales(3y)8.42%
Cap/Sales(5y)10.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y44.17%
EPS Next 2Y40.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.77%
Revenue growth 3Y-6.79%
Revenue growth 5Y-2.72%
Sales Q2Q%-18.26%
Revenue Next Year-2.59%
Revenue Next 2Y-3.64%
Revenue Next 3Y-0.12%
Revenue Next 5YN/A
EBIT growth 1Y-185.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year312.94%
EBIT Next 3Y82.25%
EBIT Next 5YN/A
FCF growth 1Y-57.44%
FCF growth 3YN/A
FCF growth 5Y-14.38%
OCF growth 1Y-42.41%
OCF growth 3Y-7.59%
OCF growth 5Y-11.46%

PLAYSTUDIOS INC / MYPS Fundamental Analysis FAQ

What is the fundamental rating for MYPS stock?

ChartMill assigns a fundamental rating of 4 / 10 to MYPS.


What is the valuation status for MYPS stock?

ChartMill assigns a valuation rating of 2 / 10 to PLAYSTUDIOS INC (MYPS). This can be considered as Overvalued.


How profitable is PLAYSTUDIOS INC (MYPS) stock?

PLAYSTUDIOS INC (MYPS) has a profitability rating of 3 / 10.


What is the expected EPS growth for PLAYSTUDIOS INC (MYPS) stock?

The Earnings per Share (EPS) of PLAYSTUDIOS INC (MYPS) is expected to grow by 44.17% in the next year.